https://www.selleckchem.com/pr....oducts/ulixertinib-b
Background The apparent diffusion coefficient (ADC) may be used as a biomarker to diagnose axial spondyloarthritis (axSpA) and monitor therapeutic response. Purpose To measure the repeatability of the ADC in healthy individuals and in patients with axSpA with and without active sacroiliitis in a test-retest set-up, and to correlate ADC to conventional magnetic resonance imaging (MRI) bone marrow edema (BME) scores and clinical findings. Material and Methods A total of 25 patients with axSpA and 24 sex- and age-matc
Like
Comment
Share
